Skip to main content

Month: August 2022

SANUWAVE Health Reports Second Quarter 2022 Financial Results & Will Host Live Conference Call With Business Update 

Eden Prairie, MN, Aug. 15, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation wound care products, reported financial results for their second quarter ending June 30, 2022, with the SEC on Friday, August 12, 2022. The Company will host a live conference call on Tuesday, August 16, 2022, at 12:30 (EDT) to provide a business update (Dial-in information below). Quarter Highlights:Over 50 systems placed to treat wounds 100% increase from the 25 systems placed in Q2 2021Over 40,000 wound treatments administeredUp from 31,000 treatments administered in Q2 2021Successfully completed MDSAP audit Company transitioned from Suwanee, GA to Eden Prairie, MN Became current on SEC filings Launched Cosmetic and Orthopedics verticals with initial sales in each“Our...

Continue reading

Eneti Inc. Announces Sale of Shareholding in Scorpio Tankers Inc.

MONACO, Aug. 15, 2022 (GLOBE NEWSWIRE) — Eneti Inc. (NYSE:NETI) (the “Company”) announced today that it sold its entire holding of 2,155,140 common shares in Scorpio Tankers Inc., a related party, for gross proceeds of approximately $83.3 million ($38.65 per share). As part of the transaction, Scorpio Tankers Inc. purchased approximately 1.3 million shares for approximately $50.0 million. About Eneti Inc. Eneti Inc. is a leading provider of installation and maintenance vessels to the offshore wind sector and has invested in the next generation of wind turbine installation vessels. The Company is listed on the New York Stock Exchange under the ticker symbol NETI. Additional information about the Company is available on the Company’s website: www.eneti-inc.com. Forward-Looking Statements Matters discussed in this press release...

Continue reading

Smart for Life Announces Q2 2022 Financial Results

Revenue Increases 401.2% Year-Over-Year to $4.3 Million for the Second Quarter of 2022 Due to Successful Acquisition Strategy Gross Profit Margin Increases to 41.6% Versus 1.1% for the Same Period Last Year MIAMI, Aug. 15, 2022 (GLOBE NEWSWIRE) — Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the health & wellness sector, marketing and manufacturing nutritional foods and supplements worldwide, today provided a business update and reported financial results for the second quarter ended June 30, 2022. “We continue to generate solid year-over-year growth with revenues increasing more than four-fold to $4.3 million for the second quarter of 2022,” stated Darren Minton, Chief Executive Officer of Smart for Life. “We also achieved a 512.7% year-over-year increase in revenue...

Continue reading

Creative Realities Reports Second Quarter 2022 Results

Announces record revenue of $10.9 million Announces growth of annual recurring revenue to $14.5 million run-rate Reaffirms 2022 Revenue Guidance to Exceed $43 millionLOUISVILLE, Ky., Aug. 15, 2022 (GLOBE NEWSWIRE) — Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX, CREXW), a leading provider of digital signage solutions, announced its financial results for the three- and six-months ended June 30, 2022. Rick Mills, Chief Executive Officer, commented “I am pleased to report that the Company generated record revenue of $10.9 million for the second quarter of 2022, a $7.6 million, or 233%, improvement over the same period in 2021. Importantly, this represents a $4.7 million increase over the pro forma combination of Creative Realities and Reflect Systems in 2021, indicative of both organic and...

Continue reading

Dewmar International Announces the Public Availability of Its Disclosure Document and Its Financial Statement for the Quarter Ended June 30, 2022

NEW YORK, NY, Aug. 15, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Dewmar International BMC Inc. announced today that its complete disclosure statements and financial reports for the quarter ended June 30, 2022 is available for download on its website. The file is not password protected and anyone can view the disclosure statements and financial statements by simply clicking on the download button. To view the complete reports, simply visit https://dewmarinternational.com and click on Financials on the top navigation row or click on the following link. https://dewmarinternational.com/financials This press release is not an offer to sell or a solicitation of an offer to buy securities. Donald Hunter, Chairman and Chief Executive Officer of Dewmar commented, “We are announcing this required information to be deemed to be providing...

Continue reading

Quipt Home Medical Reports Ongoing Operational Strength With Record Third Quarter Fiscal 2022 Financial Results

Posts Revenue Growth of 40% and Adjusted EBITDA Growth of 44% CINCINNATI, Aug. 15, 2022 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, today announced its third quarter fiscal 2022 financial results and operational highlights. These results pertain to the three-month period ended June 30, 2022 and are reported in U.S. Dollars. Financial Highlights:Revenue for Q3 2022 was $36.7 million compared to $26.2 million for Q3 2021, representing a 40% increase in revenue year-over-year. Compared to Q2 2022, the Company experienced very strong sequential organic growth of 2%.As of June 30, 2022, the Company’s backlog decreased to approximately 6,000 patients in the queue to be set up on sleep devices....

Continue reading

Avicanna Reports Q2 2022 Financial Statement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS TORONTO, Aug. 15, 2022 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused on the commercialization of evidence-based, cannabinoid-based products, is pleased to announce the filing of its interim financial statements for the three-month period ending June 30, 2022 (“Q2 2022”). “We are pleased to report on our continued progress and global commercialization efforts where we primarily focused on, and achieved, growth of our four brands in the Canadian marketplace. We also pursued continuous optimization of our operations...

Continue reading

PyroGenesis Announces Q2 2022 Results: Revenues $5.8M; Gross Margin 43%; Current Backlog of Signed and/or Awarded Contracts $35.3M

MONTREAL, Aug. 15, 2022 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (NASDAQ: PYR) (FRA: 8PY), a high-tech company (hereinafter referred to as the “Company” or “PyroGenesis”), that designs, develops, manufactures and commercializes advanced plasma processes and sustainable solutions which are geared to reduce greenhouse gases (GHG), is pleased to announce today its financial and operational results for the second quarter ended June 30th, 2022. “We have posted Q2 2022 revenues of $5.8M,” said Mr. P. Peter Pascali, CEO and Chair of PyroGenesis. “Our backlog remains above $35M, a significant level and our pipeline continues to expand. Despite gross reported revenue continuing to be impacted by delayed client and contract decisions related to ongoing international and regional logistical and resourcing...

Continue reading

Northview Fund Announces August Distribution

Not for distribution to U.S. newswire services or for dissemination in the United States. CALGARY, Alberta, Aug. 15, 2022 (GLOBE NEWSWIRE) — Northview Fund (the “Fund”) today announced its August 2022 cash distribution amounts on its outstanding Class A Units, Class C Units and Class F Units Class (collectively, the “Units”), payable on September 15, 2022 to holders of Units of record at August 31, 2022. The distribution amounts will be as follows:C$0.10476 per Class A Unit, representing approximately C$1.26 per Unit on an annualized basis;C$0.11056 per Class C Unit, representing approximately C$1.33 per Unit on an annualized basis;C$0.10807 per Class F Unit, representing approximately C$1.30 per Unit on an annualized basis;About Northview Fund The Fund is a “closed-end fund” established pursuant to a declaration of trust...

Continue reading

CAPREIT Announces August 2022 Distribution

TORONTO, Aug. 15, 2022 (GLOBE NEWSWIRE) — Canadian Apartment Properties Real Estate Investment Trust (“CAPREIT”) (TSX – CAR.UN) announced today its August 2022 monthly distribution in the amount of $0.12083 per Unit (or $1.45 on an annualized basis). The August distribution will be payable on September 15, 2022 to Unitholders of record on August 31, 2022. CAPREIT is Canada’s largest publicly-traded provider of quality rental housing. CAPREIT currently owns or has interests in approximately 67,000 residential apartment suites, townhomes and manufactured housing community sites well-located across Canada and the Netherlands with approximately $18 billion of assets under management globally. Since its Initial Public Offering in May 1997, CAPREIT has grown monthly cash distributions per Unit by 103%. For more information about CAPREIT,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.